Industry: Service & Software
Published Date: 2025-09-06
Pages: 112 Pages
Report ld: 4952655
Request Sample
Customized Report
The global CRO Services for BioPharma market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
The North America CRO Services for BioPharma market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of CRO Services for BioPharma include PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, Parexel, ICON plc, Syneos Health, Charles River Laboratories, Medpace, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global CRO Services for BioPharma market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of CRO Services for BioPharma market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Clinical Trial CRO in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Scientific Research in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the CRO Services for BioPharma value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Preclinical CRO
1.2.3 Clinical Trial CRO
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRO Services for BioPharma Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global CRO Services for BioPharma Revenue Market Share by Region (2020-2025)
2.4 Global CRO Services for BioPharma Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America CRO Services for BioPharma Market Size and Prospective (2020-2031)
2.5.2 Europe CRO Services for BioPharma Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific CRO Services for BioPharma Market Size and Prospective (2020-2031)
2.5.4 Latin America CRO Services for BioPharma Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa CRO Services for BioPharma Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global CRO Services for BioPharma Historic Market Size by Type (2020-2025)
3.2 Global CRO Services for BioPharma Forecasted Market Size by Type (2026-2031)
3.3 Different Types CRO Services for BioPharma Representative Players
4 Breakdown Data by Application
4.1 Global CRO Services for BioPharma Historic Market Size by Application (2020-2025)
4.2 Global CRO Services for BioPharma Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in CRO Services for BioPharma Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top CRO Services for BioPharma Players by Revenue (2020-2025)
5.1.2 Global CRO Services for BioPharma Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by CRO Services for BioPharma Revenue
5.4 Global CRO Services for BioPharma Market Concentration Analysis
5.4.1 Global CRO Services for BioPharma Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by CRO Services for BioPharma Revenue in 2024
5.5 Global Key Players of CRO Services for BioPharma Head office and Area Served
5.6 Global Key Players of CRO Services for BioPharma, Product and Application
5.7 Global Key Players of CRO Services for BioPharma, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America CRO Services for BioPharma Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America CRO Services for BioPharma Market Size by Type (2020-2025)
6.1.2.2 North America CRO Services for BioPharma Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America CRO Services for BioPharma Market Size by Application (2020-2025)
6.1.3.2 North America CRO Services for BioPharma Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe CRO Services for BioPharma Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe CRO Services for BioPharma Market Size by Type (2020-2025)
6.2.2.2 Europe CRO Services for BioPharma Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe CRO Services for BioPharma Market Size by Application (2020-2025)
6.2.3.2 Europe CRO Services for BioPharma Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific CRO Services for BioPharma Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific CRO Services for BioPharma Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific CRO Services for BioPharma Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific CRO Services for BioPharma Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific CRO Services for BioPharma Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America CRO Services for BioPharma Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America CRO Services for BioPharma Market Size by Type (2020-2025)
6.4.2.2 Latin America CRO Services for BioPharma Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America CRO Services for BioPharma Market Size by Application (2020-2025)
6.4.3.2 Latin America CRO Services for BioPharma Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa CRO Services for BioPharma Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa CRO Services for BioPharma Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa CRO Services for BioPharma Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa CRO Services for BioPharma Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa CRO Services for BioPharma Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 PPD (Thermo Fisher)
7.1.1 PPD (Thermo Fisher) Company Details
7.1.2 PPD (Thermo Fisher) Business Overview
7.1.3 PPD (Thermo Fisher) CRO Services for BioPharma Introduction
7.1.4 PPD (Thermo Fisher) Revenue in CRO Services for BioPharma Business (2020-2025)
7.1.5 PPD (Thermo Fisher) Recent Development
7.2 Space Peptides
7.2.1 Space Peptides Company Details
7.2.2 Space Peptides Business Overview
7.2.3 Space Peptides CRO Services for BioPharma Introduction
7.2.4 Space Peptides Revenue in CRO Services for BioPharma Business (2020-2025)
7.2.5 Space Peptides Recent Development
7.3 Aurigene Pharmaceutical Services
7.3.1 Aurigene Pharmaceutical Services Company Details
7.3.2 Aurigene Pharmaceutical Services Business Overview
7.3.3 Aurigene Pharmaceutical Services CRO Services for BioPharma Introduction
7.3.4 Aurigene Pharmaceutical Services Revenue in CRO Services for BioPharma Business (2020-2025)
7.3.5 Aurigene Pharmaceutical Services Recent Development
7.4 IQVIA
7.4.1 IQVIA Company Details
7.4.2 IQVIA Business Overview
7.4.3 IQVIA CRO Services for BioPharma Introduction
7.4.4 IQVIA Revenue in CRO Services for BioPharma Business (2020-2025)
7.4.5 IQVIA Recent Development
7.5 Labcorp Drug Development
7.5.1 Labcorp Drug Development Company Details
7.5.2 Labcorp Drug Development Business Overview
7.5.3 Labcorp Drug Development CRO Services for BioPharma Introduction
7.5.4 Labcorp Drug Development Revenue in CRO Services for BioPharma Business (2020-2025)
7.5.5 Labcorp Drug Development Recent Development
7.6 Parexel
7.6.1 Parexel Company Details
7.6.2 Parexel Business Overview
7.6.3 Parexel CRO Services for BioPharma Introduction
7.6.4 Parexel Revenue in CRO Services for BioPharma Business (2020-2025)
7.6.5 Parexel Recent Development
7.7 ICON plc
7.7.1 ICON plc Company Details
7.7.2 ICON plc Business Overview
7.7.3 ICON plc CRO Services for BioPharma Introduction
7.7.4 ICON plc Revenue in CRO Services for BioPharma Business (2020-2025)
7.7.5 ICON plc Recent Development
7.8 Syneos Health
7.8.1 Syneos Health Company Details
7.8.2 Syneos Health Business Overview
7.8.3 Syneos Health CRO Services for BioPharma Introduction
7.8.4 Syneos Health Revenue in CRO Services for BioPharma Business (2020-2025)
7.8.5 Syneos Health Recent Development
7.9 Charles River Laboratories
7.9.1 Charles River Laboratories Company Details
7.9.2 Charles River Laboratories Business Overview
7.9.3 Charles River Laboratories CRO Services for BioPharma Introduction
7.9.4 Charles River Laboratories Revenue in CRO Services for BioPharma Business (2020-2025)
7.9.5 Charles River Laboratories Recent Development
7.10 Medpace
7.10.1 Medpace Company Details
7.10.2 Medpace Business Overview
7.10.3 Medpace CRO Services for BioPharma Introduction
7.10.4 Medpace Revenue in CRO Services for BioPharma Business (2020-2025)
7.10.5 Medpace Recent Development
7.11 SGS SA
7.11.1 SGS SA Company Details
7.11.2 SGS SA Business Overview
7.11.3 SGS SA CRO Services for BioPharma Introduction
7.11.4 SGS SA Revenue in CRO Services for BioPharma Business (2020-2025)
7.11.5 SGS SA Recent Development
7.12 KCR CRO
7.12.1 KCR CRO Company Details
7.12.2 KCR CRO Business Overview
7.12.3 KCR CRO CRO Services for BioPharma Introduction
7.12.4 KCR CRO Revenue in CRO Services for BioPharma Business (2020-2025)
7.12.5 KCR CRO Recent Development
7.13 TFS HealthScience
7.13.1 TFS HealthScience Company Details
7.13.2 TFS HealthScience Business Overview
7.13.3 TFS HealthScience CRO Services for BioPharma Introduction
7.13.4 TFS HealthScience Revenue in CRO Services for BioPharma Business (2020-2025)
7.13.5 TFS HealthScience Recent Development
7.14 Caidya
7.14.1 Caidya Company Details
7.14.2 Caidya Business Overview
7.14.3 Caidya CRO Services for BioPharma Introduction
7.14.4 Caidya Revenue in CRO Services for BioPharma Business (2020-2025)
7.14.5 Caidya Recent Development
7.15 Worldwide Clinical Trials
7.15.1 Worldwide Clinical Trials Company Details
7.15.2 Worldwide Clinical Trials Business Overview
7.15.3 Worldwide Clinical Trials CRO Services for BioPharma Introduction
7.15.4 Worldwide Clinical Trials Revenue in CRO Services for BioPharma Business (2020-2025)
7.15.5 Worldwide Clinical Trials Recent Development
7.16 CTI
7.16.1 CTI Company Details
7.16.2 CTI Business Overview
7.16.3 CTI CRO Services for BioPharma Introduction
7.16.4 CTI Revenue in CRO Services for BioPharma Business (2020-2025)
7.16.5 CTI Recent Development
7.17 Advanced Clinical
7.17.1 Advanced Clinical Company Details
7.17.2 Advanced Clinical Business Overview
7.17.3 Advanced Clinical CRO Services for BioPharma Introduction
7.17.4 Advanced Clinical Revenue in CRO Services for BioPharma Business (2020-2025)
7.17.5 Advanced Clinical Recent Development
7.18 WuXi AppTec
7.18.1 WuXi AppTec Company Details
7.18.2 WuXi AppTec Business Overview
7.18.3 WuXi AppTec CRO Services for BioPharma Introduction
7.18.4 WuXi AppTec Revenue in CRO Services for BioPharma Business (2020-2025)
7.18.5 WuXi AppTec Recent Development
7.19 Pharmaron Inc.
7.19.1 Pharmaron Inc. Company Details
7.19.2 Pharmaron Inc. Business Overview
7.19.3 Pharmaron Inc. CRO Services for BioPharma Introduction
7.19.4 Pharmaron Inc. Revenue in CRO Services for BioPharma Business (2020-2025)
7.19.5 Pharmaron Inc. Recent Development
7.20 Hangzhou Tigermed Consulting
7.20.1 Hangzhou Tigermed Consulting Company Details
7.20.2 Hangzhou Tigermed Consulting Business Overview
7.20.3 Hangzhou Tigermed Consulting CRO Services for BioPharma Introduction
7.20.4 Hangzhou Tigermed Consulting Revenue in CRO Services for BioPharma Business (2020-2025)
7.20.5 Hangzhou Tigermed Consulting Recent Development
7.21 JOINN Laboratories
7.21.1 JOINN Laboratories Company Details
7.21.2 JOINN Laboratories Business Overview
7.21.3 JOINN Laboratories CRO Services for BioPharma Introduction
7.21.4 JOINN Laboratories Revenue in CRO Services for BioPharma Business (2020-2025)
7.21.5 JOINN Laboratories Recent Development
7.22 MEDICILON
7.22.1 MEDICILON Company Details
7.22.2 MEDICILON Business Overview
7.22.3 MEDICILON CRO Services for BioPharma Introduction
7.22.4 MEDICILON Revenue in CRO Services for BioPharma Business (2020-2025)
7.22.5 MEDICILON Recent Development
8 CRO Services for BioPharma Market Dynamics
8.1 CRO Services for BioPharma Industry Trends
8.2 CRO Services for BioPharma Market Drivers
8.3 CRO Services for BioPharma Market Challenges
8.4 CRO Services for BioPharma Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global CRO Services for BioPharma market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 173
USD 4900.00
(Single User License)
The global CRO Services for BioPharma market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 113
USD 4250.00
(Single User License)
The global market for CRO Services for BioPharma was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 153
USD 3950.00
(Single User License)
The global CRO Services for BioPharma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 153
USD 2900.00
(Single User License)
The global CRO Services for BioPharma market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 173
USD 4900.00
(Single User License)
The global market for CRO Services for BioPharma was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 157
USD 3950.00
(Single User License)
The global market for CRO Services for BioPharma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 106
USD 2900.00
(Single User License)
Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
Published Date: 2024-06-19
Pages: 162
USD 4900.00
(Single User License)
Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
Published Date: 2024-06-19
Pages: 145
USD 4350.00
(Single User License)
Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
Published Date: 2024-06-19
Pages: 147
USD 3950.00
(Single User License)
The global CRO Services for BioPharma market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 173
The global CRO Services for BioPharma market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 113
The global market for CRO Services for BioPharma was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 153
The global CRO Services for BioPharma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 153
The global CRO Services for BioPharma market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 173
The global market for CRO Services for BioPharma was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 157
The global market for CRO Services for BioPharma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 106
Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
Published: 2024-06-19
Pages: 162
Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
Published: 2024-06-19
Pages: 145
Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
Published: 2024-06-19
Pages: 147
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now